Alagille Syndrome and Associated Cardiac Pathologies: A Comprehensive Exploration of the Interplay between Genetic Factors and Cardiovascular Manifestations
Main Article Content
Abstract
Alagille Syndrome (ALGS) stands as a multifaceted genetic disorder renowned for its distinctive cholestatic liver disease and characteristic facial features. Beyond the hepatic implications, ALGS has been increasingly recognized for its intricate association with a spectrum of congenital heart diseases, presenting a challenging clinical scenario. This article elucidates the complex interrelation between Alagille Syndrome and various cardiac anomalies, delving into the underlying genetic mechanisms and clinical implications. By synthesizing current research, we aim to enhance the understanding of clinicians and researchers regarding the nuanced cardiovascular manifestations of Alagille Syndrome, paving the way for improved diagnostic strategies and targeted interventions.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Kamath BM, Spinner NB, Emerick KM, et al.. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004; 109: 1354-8.
II. Akagi K, Tanaka T, Baba S. Successful living donor liver transplantation after stent implantation in a patient with Alagille syndrome and severe bilateral pulmonary artery stenosis. Cardiol Young 2018; 28: 1465-7.
III. Chen H. Alagille Syndrome. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, USA: 2015; 1-8.
IV. Shendge H, Tullu MS, Shenoy A, et al.. Alagille syndrome. Indian J Pediatr 2002; 69: 825-7.
V. Ahn KJ, Yoon JK, Kim GB, et al.. Alagille syndrome and a JAG1 mutation: 41 cases of experience at a single centerr. Korean J Pediatr 2015; 58: 392-7.
VI. Kayhan A, Yashar Ilkhchoui Y, Venu N, et al.. Multiple abdominal vascular anomalies in a patient with Alagille syndrome. J Vasc Interv Radiol 2010; 21: 937-40.
VII. Rahmoune FC, Bruyère M, Tecsy M, Benhamou D. Alagille syndrome and pregnancy: anesthetic management for cesarean section. Int J Obstet Anesth 2011; 20: 355-8.
VIII. Albayram F, Stone K, Nagey D, et al.. Alagille syndrome: prenatal diagnosis and pregnancy outcome. Fetal Diagn Ther 2002; 17: 182-4.
IX. Baykan A, Argun M, Özyurt A, et al.. Cutting balloon angioplasty and stent implantation for left pulmonary artery stenosis in a case with Alagille syndrome. Turk Gogus Kalp Dama 2014; 22: 642-4.
X. Bérard E, Sarles J, Triolo V, et al.. Renovascular hypertension and vascular anomalies in Alagille syndrome. Pediatr Nephrol 1998; 12: 121-4.
XI. Brodsky MC, Cunniff C. Ocular anomalies in the alagille syndrome (arteriohepatic dysplasia). Ophthalmology 1993; 100: 1767-74.
XII. Cambiaghi S, Riva S, Ramaccioni V, et al.. Steatocystoma multiplex and leuconychia in a child with Alagille syndrome. Br J Dermatol 1998; 138: 150-4.
XIII. Cardona J, Houssin D, Gauthier F, et al.. Liver transplantation in children with Alagille syndrome: a study of twelve cases. Transplantation 1995; 60: 339-42.
XIV. Cheng KW, Huang JJ, Wang CH, et al.. Anesthetic management of a patient with Alagille’s syndrome undergoing living donor liver transplantation without blood transfusion. Chang Gung Med J 2004; 27: 449-53